Tests in

Macrocephaly Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    CUL4B • EZH2 • GLI3 • MED12 • NFIX • NSD1 • PHF6 • PIK3CA • PTCH1 • PTEN • UPF3B
View Test

Marginal Zone Lymphoma (MZL) FISH Panel

  • Test Code:
    7454
  • Department:
    Cancer FISH
  • Test Synonyms:
    MZL FISH • MALT FISH
View Test

Maternal Cell Rule-Out

  • Test Code:
    1980
  • Department:
    Molecular Genetics
  • Test Synonyms:
    Maternal Cell Contamination Testing • Maternal Cell Rule-Out • MCC • MCRO
View Test

Maturity-Onset Diabetes of the Young Panel

  • Test Code:
    1895
  • Department:
    Molecular Genetics
  • Test Synonyms:
    MODY • ABCC8 • AKT2 • BLK • CISD2 • CP • EIF2AK3 • FOXP3 • GATA6 • GCK • GLIS3 • HNF1A • HNF1B • HNF4A • IER3IP1 • INS • KCNJ11 • KLF11 • NEUROD1 • NEUROG3 • PAX4 • PDX1 • PTF1A • RFX6 • SLC2A2 • WFS1
View Test

Melanoma Panel

  • Test Code:
    4900
  • Department:
    Solid Tumors
  • Test Synonyms:
    BRAF • NRAS • KIT for melanoma
View Test

MET Amplification - FISH

  • Test Code:
    8500
  • Department:
    Cancer FISH
  • Test Synonyms:
View Test

MGMT Methylation

  • Test Code:
    5005
  • Department:
    Solid Tumors
  • Test Synonyms:
    MGMT
View Test

Microcephaly Panel

  • Test Code:
  • Department:
    Molecular Genetics
  • Test Synonyms:
    ASPM • ATR • ATRX • CASK • CDK5RAP2 • CDKL5 • CENPJ • CEP152 • DHCR7 • FOXG1 • IER3IP1 • MCPH1 • MECP2 • MYCN • NIPBL • PCNT • RAB18 • RAB3GAP1 • RAB3GAP2 • RBBP8 • SLC25A19 • SLC9A6 • STIL • TCF4 • TUBB3 • UBE3A • WDR62 • ZEB2
View Test

Migraine and Strokes Panel

  • Test Code:
    1135
  • Department:
    Molecular Genetics
  • Test Synonyms:
    CADASIL • CARASIL • Familial hemiplegic migraine • ATP1A2 • CACNA1A • COL4A1 • HTRA1 • NOTCH3 • POLG • SCN1A • SLC2A1
View Test

Miller-Dieker FISH

View Test
Innovations in Testing
View All Tests

The Knight Cancer Institute at Oregon Health & Science University is a pioneer in the field of precision cancer medicine. The institute's director, Brian Druker, M.D., helped prove it was possible to shut down just the cells that enable cancer to grow. This breakthrough has made once-fatal forms of the disease manageable and transformed how cancer is treated. The OHSU Knight Cancer Institute is the only National Cancer Institute-designated Cancer Center between Sacramento and Seattle – an honor earned only by the nation's top cancer centers. It is headquarters for one of the National Cancer Institute's largest research collaboratives, SWOG, in addition to offering the latest treatments and technologies as well as hundreds of research studies and clinical trials.

Learn More